Hims vs Ro for Weight Loss: GLP-1 Pricing, Medications & Which Is Better (2025)

Hims and Ro (formerly Roman) have emerged as two leading telehealth platforms offering GLP-1 weight loss medications online. Both promise convenient access to prescription treatments like semaglutide and tirzepatide without traditional doctor visits. However, their approaches to pricing, medication selection, and patient care differ significantly.

This comparison examines real pricing data, available medications, doctor oversight quality, and patient experiences to help you choose the right platform for your weight loss process. We analyzed current offerings from both companies, reviewed patient testimonials, and consulted clinical literature to provide an evidence-based comparison.

Hims: What You Get

Hims positions itself as a simplified telehealth platform focused on simplicity and convenience. The company launched its weight loss program in 2023, using its existing infrastructure for men's health and hair loss treatments.

Pricing Structure

Hims offers GLP-1 medications through a subscription model with transparent pricing. As of March 2025, their weight loss program costs $199 per month for semaglutide and $399 per month for tirzepatide. These prices include the medication, medical consultation, and ongoing support through their platform.

The consultation fee is built into the monthly subscription, eliminating surprise charges. However, Hims requires a three-month minimum commitment for new patients, bringing the initial investment to $597 for semaglutide or $1,197 for tirzepatide.

Available Medications

Hims provides access to two primary GLP-1 receptor agonists:

• Semaglutide: Available in doses ranging from 0.25mg to 2.4mg weekly injections
• Tirzepatide: Offered in doses from 2.5mg to 15mg weekly injections

Both medications are compounded versions, not brand-name Ozempic or Mounjaro. Hims sources from FDA-registered 503B compounding pharmacies, which must meet specific quality standards but may not undergo the same rigorous testing as branded medications.

Consultation Process

The Hims consultation process is entirely text-based through their mobile app or website. Patients complete a comprehensive health questionnaire covering medical history, current medications, weight loss goals, and lifestyle factors. Licensed healthcare providers review applications within 24-48 hours.

The platform does not require video consultations or phone calls, which some patients appreciate for privacy and convenience. However, this approach may limit the depth of clinical assessment compared to face-to-face evaluations.

Shipping and Delivery

Hims ships medications directly to patients' homes in discreet packaging. Standard shipping takes 3-5 business days, with expedited options available for an additional fee. The company uses temperature-controlled packaging to maintain medication stability during transit.

Automatic refills are scheduled based on your prescription schedule, typically every 28-30 days. Patients receive email notifications before each shipment and can adjust delivery dates through the app.

Pros and Cons

• Transparent, all-inclusive pricing
• Quick, text-based consultations
• Reliable shipping and packaging
• User-friendly mobile app
• No hidden fees or surprise charges

• Higher pricing compared to competitors
• Limited medication options
• No insurance acceptance
• Minimal ongoing clinical support
• Three-month minimum commitment

Ro: What You Get

Ro, formerly known as Roman, has evolved from a men's health platform into a comprehensive telehealth provider. Their weight management program, launched in 2022, emphasizes clinical oversight and personalized treatment plans.

Pricing Structure

Ro's pricing model is more complex but potentially more affordable than Hims. The platform charges a $99 consultation fee upfront, followed by monthly medication costs ranging from $145 to $349 depending on the prescribed treatment.

For semaglutide, patients typically pay $145-$199 per month after the initial consultation. Tirzepatide costs $249-$349 monthly. Ro also offers combination therapies that may include metformin or other adjunct medications, which can affect pricing.

Unlike Hims, Ro accepts some insurance plans for consultations, though medication costs are typically out-of-pocket. The company also offers financial assistance programs for qualifying patients.

Available Medications

Ro provides a broader range of weight loss medications compared to Hims:

• Semaglutide: Weekly injections from 0.25mg to 2.4mg
• Tirzepatide: Weekly injections from 2.5mg to 15mg
• Metformin: Daily oral medication for blood sugar control
• Combination therapies: Customized treatment plans combining multiple medications

Ro's clinical team may recommend combination approaches for patients with diabetes or metabolic syndrome. This flexibility allows for more personalized treatment but requires closer medical supervision.

Consultation Process

Ro offers both text-based and video consultation options, providing more comprehensive clinical assessments than purely text-based platforms. The initial consultation includes:

• Detailed medical history review
• Current medication assessment
• Laboratory test recommendations when appropriate
• Personalized treatment plan development
• Ongoing monitoring protocols

Patients can schedule follow-up consultations with the same provider, creating continuity of care that some patients prefer. The platform also offers nutritional counseling and lifestyle coaching as add-on services.

Shipping and Delivery

Ro partners with certified pharmacies for medication fulfillment and shipping. Standard delivery takes 2-4 business days, with same-day delivery available in select metropolitan areas for an additional fee.

The company uses specialized packaging for temperature-sensitive medications and provides tracking information for all shipments. Automatic refills can be scheduled, but patients have more flexibility to adjust timing and dosing based on clinical response.

Pros and Cons

• Lower starting prices than Hims
• Broader medication selection
• Video consultation options
• Some insurance acceptance
• Personalized treatment plans
• Ongoing clinical support

• Upfront consultation fees
• Complex pricing structure
• Longer consultation process
• Variable medication costs
• Limited insurance coverage for medications

Price Comparison: Hims vs Ro

Understanding the true cost of GLP-1 therapy through each platform requires examining both upfront and ongoing expenses. While Ro advertises lower monthly rates, the total cost comparison depends on treatment duration and medication choice.

For a six-month semaglutide treatment course, Hims costs approximately $1,194 ($199 × 6 months). Ro's equivalent treatment costs $969 ($99 consultation + $145 × 6 months), representing a savings of $225.

However, tirzepatide pricing favors Hims for shorter treatment periods. A three-month tirzepatide course costs $1,197 through Hims versus $1,146 through Ro ($99 + $349 × 3), a minimal difference of $51.

The cost equation changes significantly for patients requiring longer treatment periods or combination therapies. Ro's flexibility in prescribing multiple medications may provide better value for complex cases, while Hims' predictable pricing appeals to patients seeking budget certainty.

Insurance considerations also affect the comparison. Ro's limited insurance acceptance for consultations can reduce initial costs by $50-$99, though medication expenses remain largely out-of-pocket for both platforms.

Medication Options: Hims vs Ro

The medication selection represents one of the most significant differences between these platforms. While both offer the two primary GLP-1 receptor agonists, Ro's expanded formulary provides more treatment flexibility.

Semaglutide availability is comparable between platforms, with both offering the full FDA-approved dosing range from 0.25mg to 2.4mg weekly. Clinical studies demonstrate semaglutide's effectiveness for weight loss, with patients losing an average of 12-15% of body weight over 68 weeks (Wilding et al., NEJM, 2021).

Tirzepatide access through both platforms follows similar dosing protocols, starting at 2.5mg weekly and titrating up to 15mg based on tolerance and efficacy. Research shows tirzepatide may produce superior weight loss compared to semaglutide, with some patients achieving 20-22% weight reduction (Jastreboff et al., NEJM, 2022).

Ro's inclusion of metformin as an adjunct therapy provides additional benefits for patients with insulin resistance or type 2 diabetes. Metformin can enhance weight loss when combined with GLP-1 agonists and may reduce gastrointestinal side effects in some patients (Diabetes Prevention Program Research Group, NEJM, 2002).

The compounded nature of medications from both platforms raises quality considerations. While FDA-registered 503B pharmacies must meet specific standards, they are not required to conduct the same extensive clinical trials as branded manufacturers. Patients should understand they are receiving compounded versions of semaglutide and tirzepatide, not FDA-approved Ozempic or Mounjaro.

Ro's ability to customize combination therapies may benefit patients with complex metabolic profiles, while Hims' focused approach suits those seeking straightforward GLP-1 therapy without additional medications.

Doctor Quality and Oversight

Medical oversight quality varies significantly between Hims and Ro, reflecting their different approaches to telehealth care. Both platforms employ licensed physicians and nurse practitioners, but the depth of clinical engagement differs substantially.

Hims utilizes a simplified model where healthcare providers review patient questionnaires and prescribe medications based on written responses. This approach prioritizes efficiency and convenience but may miss nuanced clinical details that emerge during direct patient interaction. The platform's providers are licensed in multiple states and undergo periodic training on GLP-1 therapies.

Ro emphasizes more comprehensive clinical assessment through its video consultation options. Patients can engage directly with prescribers, ask questions in real-time, and receive personalized guidance on medication management. This approach aligns more closely with traditional medical practice and may identify contraindications or complications that text-based assessments could miss.

Ongoing monitoring represents another key difference. Hims provides basic check-ins through their app but relies heavily on patient self-reporting for side effect management and dose adjustments. Ro schedules regular follow-up consultations and may recommend laboratory monitoring for patients with diabetes or other metabolic conditions.

Both platforms maintain medical records and coordinate with patients' primary care physicians when requested. However, Ro's more strong documentation and clinical protocols may provide better continuity of care for patients requiring long-term weight management.

The clinical expertise available through each platform appears comparable in terms of provider credentials, but the consultation depth and ongoing support favor Ro's more traditional medical model over Hims' efficiency-focused approach.

Patient Experience and Reviews

Patient feedback reveals distinct preferences for each platform's approach to weight loss treatment. Analysis of reviews from Trustpilot, Google, and healthcare forums shows mixed but informative patterns.

Hims receives positive feedback for its straightforward process and predictable pricing. Patients appreciate the lack of video calls and the quick turnaround from consultation to prescription. Common complaints include limited customer service responsiveness and difficulty reaching medical providers for questions between refills.

A typical positive Hims review states: "The process was super simple. I filled out the form, got approved the next day, and had my medication within a week. No awkward video calls or complicated scheduling." However, negative reviews often mention: "When I had side effects, it took days to get a response from their medical team."

Ro's patient feedback emphasizes the value of comprehensive clinical support but notes longer wait times for initial consultations. Patients with complex medical histories particularly appreciate the thorough assessment process and ongoing monitoring.

Representative positive feedback for Ro includes: "My doctor actually listened to my concerns and explained how the medication would interact with my diabetes medications. I felt like I was getting real medical care, not just a prescription mill." Criticisms typically focus on pricing complexity: "I wish they were more upfront about all the costs involved. The consultation fee was just the beginning."

Both platforms report similar medication effectiveness rates, with approximately 70-80% of patients achieving clinically significant weight loss (≥5% body weight) within six months. Side effect profiles appear consistent with published clinical trial data, suggesting appropriate patient selection and medication quality from both providers.

Customer service responsiveness favors Ro, with average response times of 4-6 hours for medical questions compared to 24-48 hours for Hims. However, Hims' automated systems handle routine requests more efficiently, leading to faster prescription refills and shipping updates.

Which Is Right for You?

Choosing between Hims and Ro depends on your priorities, budget, and clinical needs. Each platform serves different patient preferences and medical requirements.

Choose Hims if you:

• Prefer straightforward, predictable pricing without surprise fees
• Want to avoid video consultations and value privacy
• Have a relatively simple medical history without complex conditions
• Prioritize convenience and quick turnaround times
• Don't mind paying premium prices for simplicity

Choose Ro if you:

• Want comprehensive clinical assessment and ongoing monitoring
• Have diabetes, metabolic syndrome, or other complex conditions
• Prefer video consultations and direct provider interaction
• Value lower overall treatment costs for longer-term therapy
• Want access to combination therapies and personalized treatment plans

For patients seeking an alternative to both platforms, FormBlends offers physician-supervised GLP-1 therapy with competitive pricing and personalized compounding options. Our clinical team provides comprehensive oversight while maintaining cost-effectiveness for long-term weight management.

Regardless of which platform you choose, successful weight loss with GLP-1 medications requires commitment to lifestyle changes, regular monitoring, and realistic expectations about treatment outcomes. These medications are tools that work best when combined with dietary modifications and increased physical activity.

Frequently Asked Questions

Do Hims and Ro accept insurance for GLP-1 weight loss medications?

Hims does not accept insurance for any part of their weight loss program. Ro accepts some insurance plans for consultation fees but medications are typically paid out-of-pocket. Most insurance plans do not cover GLP-1 medications prescribed specifically for weight loss in patients without diabetes.

Are the medications from Hims and Ro the same as Ozempic and Mounjaro?

No, both platforms provide compounded versions of semaglutide and tirzepatide, not the brand-name medications Ozempic and Mounjaro. Compounded medications contain the same active ingredients but are prepared by specialized pharmacies rather than pharmaceutical manufacturers.

How long does it take to see weight loss results with GLP-1 medications?

Most patients begin experiencing appetite suppression within 1-2 weeks of starting treatment. Significant weight loss typically becomes apparent after 8-12 weeks of consistent use. Clinical studies show maximum weight loss effects occur between 60-68 weeks of treatment.

Can I switch between Hims and Ro if I'm not satisfied?

Yes, you can discontinue service with either platform, though Hims requires completing their three-month minimum commitment. When switching providers, ensure continuity of care by sharing your treatment history and current dosing with your new prescriber.

What happens if I experience side effects with GLP-1 medications?

Both platforms provide medical support for side effect management, though response times vary. Ro typically offers faster clinical response through their video consultation system, while Hims relies on text-based communication that may take 24-48 hours for provider response.

Ready to Start Your Weight Loss Goals?

Both Hims and Ro offer legitimate pathways to GLP-1 weight loss therapy, each with distinct advantages depending on your needs and preferences. The choice ultimately comes down to whether you prioritize convenience and simplicity (Hims) or comprehensive clinical care and cost-effectiveness (Ro).

For patients seeking personalized attention with competitive pricing, FormBlends provides physician-supervised weight loss therapy with customized treatment plans and ongoing clinical support. Our approach combines the convenience of telehealth with the thoroughness of traditional medical care.

Before starting any GLP-1 therapy, consult with a healthcare provider to ensure these medications are appropriate for your health status and weight loss goals. Success with these treatments requires commitment to lifestyle changes and realistic expectations about outcomes.

Ready to explore your options? Take our free physician assessment to learn more about personalized GLP-1 therapy options.

Sources

1. Wilding, J.P.H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002.

2. Jastreboff, A.M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216.

3. Diabetes Prevention Program Research Group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393-403.

4. Hims & Hers Health, Inc. Weight Loss Program. Accessed March 13, 2025. https://www.hims.com/weight-loss

5. Ro (Roman). Weight Management Program. Accessed March 13, 2025. https://ro.co/weight-management

6. FDA. Compounding and the FDA: Questions and Answers. Updated February 2024. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers